NCT00648349View on ClinicalTrials.gov

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Healthy
Interventions
DRUG

Rabeprazole Sodium Delayed-Release Tablets 20 mg

20mg, single dose fasting

DRUG

Aciphex® Delayed-Release Tablets 20 mg

20mg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648349 - Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg | Biotech Hunter | Biotech Hunter